.

Friday, May 10, 2019

Assignment 3 Essay Example | Topics and Well Written Essays - 1000 words - 7

Assignment 3 - render Exampleso one of the poorest states because almost 70% of its residents live on less than $2 per solar day (Lee 2).The Indian glaring law draft, implemented in 2005 fully complies with standards of organizations such as TRIPS and WTO (Lee 2). The essay pass on shed more light on the Novartis AGs patent issue with the Indian regime, whether drug companies should have multiple patents and if the tourist courts ruling was called for.In 2006, pubic louse patients, lawyers and non-governmental organizations convened at the Novartis offices in India, hailing the courts move of rejecting Novartis case where the company had sued Indian patent offices for declining its application to manufacture Glivec drugs (Lee 6). This is because according to wellness official, by granting Novartis a patent, the drug would become expensive for many an(prenominal) people not only in India but also in the entire world. Novartis move was not only an appeal against Indian patent o ffices but also aimed at TRIPS who according to Novartis have an incompatible and unconstitutional section 3(d), a pedagogy that the high court refuted vehemently (Basheer & Reddy 5). Section 3(d), which according to the patents Act states that new substances ought to show greater qualification to be patentable (Basheer & Reddy 5). Novartis on its part argues that the section be redrafted because some words such as efficacy are too general and entail clear definition for better understanding (Basheer & Reddy 5).According to researches so far conducted, Glivec is one of the best drugs ever manufactured by Novartis. Its main role is to treat degenerative Myeloid Leukemia (CML), a disease known to affect approximately 5,000 people in the United States every year (Lee 18). The drug works much better compared to others because it not only dissolves faster but also targets cancer proteins besides being ten times faster and effective (Lee 18). In 1993, Novartis applied for patents in m any states globally but not in India because the nations 1970 Act

No comments:

Post a Comment